THE REMARKABLE POWER OF METHYLENE BLUE: FROM FABRIC DYE TO HEALTH ALLY

ABSTRACT

This paper illuminates the extraordinary potential of Methylene Blue, transcending its historical roots as a textile dye to emerge as a versatile and promising ally in the realm of human health and longevity. Methylene Blue’s wide-ranging therapeutic benefits span a diverse spectrum of medical conditions, from neurodegenerative diseases like Alzheimer’s to cancer treatment, pain management, and wound healing. Its unique molecular properties enable it to step in during moments of cellular distress, bolstering energy production in mitochondria, our cell’s powerhouses, and acting as a potent antioxidant to combat excessive oxidative stress throughout the body. In addition to its impressive biological impact, Methylene Blue has proven its mettle on the battlefield, serving as a vital tool for malaria prevention and treatment during World War II. As research continues to unveil its multifaceted mechanisms and applications, Methylene Blue holds the promise of addressing an array of modern health challenges, offering a potential path towards improved human well-being, heightened physiological performance and longevity.

METHYLENE BLUE

Methylene Blue may seem like a forgotten, antiquated pharmaceutical relic from the past, but this century-old compound is making waves in both scientific and public circles for its potential to transform human health and longevity. In this paper, we will explore Methylene Blue, the first man-made drug, shedding light on its history, medical applications, recent research, and its potential contributions to human health, wellness, and longevity.

Methylene Blue has been found to have profound therapeutic uses and potential in a wide variety of medical applications, such as treatment or management of Alzheimer’s/ dementia/Parkinson’s Diseases, Cancer treatment and prevention, stroke and stroke management, cognitive decline and restricted/ reduced cerebral blood flow, traumatic brain injury (TBI), depression and bi-polar disease, shock, UV sun damage, inflammation, sepsis, malaria, methemoglobinemia, blood disinfection, pain management, cyanide and carbon monoxide poisoning, erectile disfunction, multiple sclerosis, spinal cord injury, parasitic infection, radiation-induced tissue damage, diabetes, ulcers, psoriasis and eczema, viral/ bacterial/fungal infections, wound healing, liver fibrosis and fatty liver disease, tissue and organ damage due to excessive alcohol consumption, IBD, bone loss prevention, tinnitus, chemotherapy-induced neuropathy, glaucoma, hair loss, epilepsy, chronic inflammation and arthritis.^{1, 2, 3, 6, 8, 10, 11, 12, 14} Additionally, Methylene Blue has clinically demonstrated potential for anti-aging and health-enhancing benefits such as increasing collagen and elastin in human skin, UV sun protection, enhanced cellular respiration and energy production, increased attention, memory and overall cognitive performance, and as a compliment to red-light, near-infrared light, and broad-spectrum wavelength light therapies. Methylene Blue is considered as one of the required medications to have in any hospital by the World Health Organization and is listed on its list of essential medications.^7,10,11,15 To fully understand how a compound initially synthesized as an industrial textile dye can be so impactful to such a broad range of medical, wellness and longevity issues, it is helpful to have an understand the background and mechanisms of action of Methylene Blue.

HISTORICAL ROOTS

Before the 1700s, the production of cotton and wool textiles relied heavily on manual labor in regions like China, Central America, the Middle East, and Europe. However, the onset of the First Industrial Revolution between 1760 and 1840 brought about a revolutionary transformation in textile manufacturing, leading the charge in technological advancements compared to other emerging industries. Innovative mechanized equipment specifically designed for cotton textile production disrupted the conventional norms, altering the cost structure and accessibility of high-quality, mass-produced textile goods for both industrial applications and consumer markets on a massive scale.

As the late 1800s rolled in, marking the era of the so-called Second Industrial Revolution, textile automation continued to evolve, powered by steam technology and improved iron production capabilities. This wave of progress primarily unfolded in countries like Great Britain, the United States, Belgium, and France. The outcome was the development of advanced heavy machinery, which further escalated production capacities for textile manufacturers, meeting the surging demand for cotton and wool textiles. The introduction of this high- powered technology revolutionized the textile industry, increasing the productivity of factory workers exponentially, with some estimates suggesting a 40 to 500-fold increase in output. While these advancements had a positive impact on wool and linen textiles, it was in the realm of cotton that the most significant leaps in productivity were witnessed¹².

Indigo, famously recognized as “blue gold,” boasts a rich history spanning over 6,000 years as a predominantly sought-after dye, primarily for cotton yarn used in crafting denim fabric, but also for wool and silk textiles. The name “Indigo” itself stems from a linguistic evolution originating from Roman, Italian, and English languages, derived from the term “India.” Once the primary global source of commercial Indigo during that era, India supplied much of the demand for this valuable dye. However, as industrial capacity and market requirements for cotton textiles surged, the need for alternative dye sources became increasingly pressing.

The rise of the research and manufacturing of synthetic dyes in response to these industrial needs perfectly aligned with the career trajectory of Heinrich Caro, a Polish-born research scientist. Born at the tail end of the initial industrial revolution in the late 1830s and well ahead of the second wave in the late 19th century, Heinrich embarked on a career journey that spanned textile production and chemical engineering. His professional path eventually led him to the precursor of the renowned German chemical giant BASF. Revered as a creative research chemist, an adept patent specialist, and a visionary manager skilled in science-based chemical technology, Heinrich assumed the role of spearheading Indigo research at BASF.

In a groundbreaking collaboration with the distinguished German scientist Adolf von Baeyer, Heinrich Caro achieved a significant milestone in 1876—the synthesis of the first synthetic Indigo dye, famously known as Methylene Blue. This accomplishment marked a pivotal moment in the history of chemistry and industrial innovation. Throughout his illustrious career, Caro played an instrumental role in establishing the foundations of industrial research laboratories, forging critical connections between academic and industrial chemistry, contributing to the development of modern patent law, and becoming a prominent figure in the evolution of the modern chemical industry. Adolf von Baeyer, in his own right, attained similar acclaim and recognition, ultimately receiving the Nobel Prize in 1905 for his lifelong dedication to advancing organic chemistry and revolutionizing the chemical industry through his pioneering work with organic dyes.

THE FIRST SYNTHETIC DRUG

The emergence of synthetic dyes as a revolutionary development in textile technology during the late 19th century also opened unexpected doors in the realm of medicine. At the time, the terminologies “dye” and “drug” were frequently used interchangeably, reflecting a limited understanding of how certain compounds influenced the human body. It was only later that these compounds’ therapeutic properties became apparent. In 1886, a promising young doctor and researcher, Paul Ehrlich, who would later in his career also go on to earn the Nobel Prize, capitalized on his observations, as well as those of his peers, to identify Methylene Blue as an ideal candidate for studying microbes and cells in laboratory settings, particularly under the microscope. This remarkable dye exhibited the unique ability to stain cells by binding to their structures, making it a valuable tool for scientific inquiry.

In the course of these laboratory experiments, Methylene Blue’s intriguing properties became even more evident as it occasionally demonstrated the capacity to inactivate the bacteria it was applied to for close examination. Of particular note, Ehrlich observed that Methylene Blue had a fascinating effect on the live neurons of the malaria-causing parasite, turning them blue. This led to an audacious hypothesis—that Methylene Blue might hold the potential to selectively target and combat malaria within the human body. Although the notion that the blue stain color itself could isolate and incapacitate the parasite turned out to be a misconception, Ehrlich’s groundbreaking work nonetheless bore fruit when he successfully treated human subjects for malaria in 1891 using Methylene Blue. In this remarkable turn of events, Methylene Blue earned the distinction of being the first synthetic compound employed as a human drug, marking a significant milestone in the history of medicine (Han, 2021).

While Paul Ehrlich’s success with Methylene Blue marked a significant achievement, its application in the medical field remained relatively modest, primarily due to the dominance of quinine—a plant bark-derived chemical compound with a proven track record in treating malaria. It wasn’t until existing malaria treatments began losing their effectiveness that Methylene Blue was mobilized for action during World War II, specifically for the prevention and treatment of malaria among US troops stationed in the Pacific theater. Its usage among the soldiers served an additional purpose: military leadership could easily confirm medication compliance, as therapeutic levels of Methylene Blue turned the urine of those taking it a distinctive shade of blue. Eventually, complaints about this unmistakable indicator led to the development of Hydroxychloroquine, a Methylene Blue derivative, which successfully replaced its predecessor.

Moreover, the unintentional discovery of penicillin in 1928, often celebrated as the birth of modern antimicrobial therapy, overshadowed the earlier accomplishments of organic dyes like Methylene Blue, even though they demonstrated compelling antimicrobial effects nearly 50 years before penicillin’s discovery. Given the rising threat of drug-resistant bacteria, there is a growing case for revisiting dye-derived antimicrobial agents as a means to alleviate the overused reliance on systemic antibiotics and manage the gradual emergence of “superbugs”^5. While Methylene Blue has endured as a staple dye in the textile industry and laboratories, its role as a designated medication for numerous documented medical applications has gradually faded from the collective awareness of many medical and research professionals. It wasn’t until the mid to late 2000s that researchers started to embark on a re-evaluation of Methylene Blue, delving into its mechanisms of action and its potential in treating contemporary diseases. Unlike Paul Ehrlich, who primarily attributed Methylene Blue’s microbe-inactivating properties to its color and staining capabilities, modern scientific inquiry has begun to unveil the intricate mechanisms underpinning its wide-ranging effects on the human body. These effects largely revolve around supporting or enhancing human metabolic activity, alleviating oxidative stress, and the crucial role of our mitochondria in our overall health.

ROLE IN MITOCHONDRIAL AND METABOLIC HEALTH

Known as the “Powerhouse of the cells,” mitochondria are diminutive, double-membrane organelles ubiquitous in most human cells, responsible for generating a significant portion of our cellular energy. Beyond energy production, mitochondria also orchestrate essential functions such as cellular signaling, growth, and programmed cell death. Notably, the quantity of mitochondria in a given cell can vary substantially depending on the cell type. At the heart of the mitochondria energy generation process lies the production of adenosine triphosphate (ATP), a vital energy molecule produced only by mitochondria. The production of ATP hinges on an electrochemical process pivotal to our cellular metabolism—the efficient transport of electrons from the nutrients we consume into our cells for conversion into energy. Known as glycation, this process allows oxygen molecules to convert glucose into energy through a cellular mechanism known as the Electron Transport Chain. As part of this electron transport process, some cellular oxygen resources remain incompletely utilized in the energy creation process, giving rise to a group of highly reactive compounds collectively known as Reactive Oxygen Species (ROS). It’s worth noting that mitochondria serve as the primary source of ROS within the human body.¹³

In the delicate balance of a normally functioning cell, modest levels of Reactive Oxygen Species (ROS) serve as a critical cellular signaling mechanisms, indicating and managing physiological stress. However, when cells become damaged or are exposed to prolonged periods of heightened stress, an excess production of ROS, beyond the body’s regulatory capacity, triggers a condition known as oxidative stress. Any disruption or impairment of this finely tuned cellular metabolism, hindering the smooth progress of electrons along the Electron Transport Chain for conversion into ATP (cellular energy), results in cellular dysfunction and ultimately contributes to malfunction and disease within the organism. The specific manifestations of these malfunctions vary depending on the location and extent of the breakdown in the process. The consequences may encompass an array of disorders, ranging from irritating, non-life-threatening conditions like eczema and psoriasis to the development of cancer and perilous genetic mutations. Under extreme, yet increasingly common pathological circumstances, ROS production intensifies, setting in motion an uncontrolled spiral of elevated ROS levels, inflammation, nerve damage, and additional forms of cellular stress, further exacerbating mitochondrial impairment and cellular damage caused by excessive ROS (Reactive Oxygen Species).

The prevalence of environmental toxins in skincare, personal care, and household cleaning products is on the rise. A collaborative study involving the University of Notre Dame, Indiana University, and the University of Toronto revealed that more than 50% of cosmetics contained substantial concentrations of PFAS ingredients, known to have severe implications for human health, even at minuscule doses. These chemicals have established connections with various cancers, disruptions to the immune system, and detrimental effects on developmental and reproductive systems. Although most skincare and personal care items undergo testing to ensure they do not cause immediate issues, they seldom, if ever, undergo assessments for potential long-term health consequences⁹ . When these substances are ingested or permeate the skin, they interfere with the proper functioning of mitochondria, leading to an escalation in the production of Reactive Oxygen Species (ROS) and an inflammatory response within the body, culminating in adverse effects. Similarly, inflammation that can impair and damage mitochondria resulting from poor dietary choices and a lack of regular physical activity has been identified as a fundamental contributor to the development of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, among others¹³. This dual assault on our mitochondrial well-being, stemming from both external toxins and lifestyle factors, underscores the urgent need for increased awareness and proactive measures to safeguard our mitochondrial health.

ADDRESS ROOT CAUSE MECHANISMS FOR DISEASE

In the intricate tapestry of our existence, the human body stands as a testament to both divine wisdom and evolutionary marvel. It is a well-designed machine, inherently equipped to resist disease and steadfastly maintain its harmonious balance. However, this delicate equilibrium can be disrupted when external natural or man-made forces such as chemical toxins in skin care, home cleaning products and our food supplies, or poor dietary and lifestyle stressors, exceed the body’s natural defenses and metabolic capabilities, ushering in the onset of sickness and maladies. Many of today’s most pressing health challenges, as previously enumerated, can ultimately be traced back to a common root cause: the presence or overabundance of Reactive Oxygen Species (ROS) and inflammation within the body caused by exogenic environmental and lifestyle choices. These lifestyle and environmental conditions cause oxidative stress—an intricate interplay between the chronic release of ROS and the ensuing systemic inflammation as our immune system endeavors to safeguard and heal the body. It is within this context that Methylene Blue emerges as a profound ally in confronting contemporary ailments.

Despite its unassuming molecular structure, Methylene Blue possesses a remarkable capacity, akin to oxygen, as a potent electron acceptor. This inherent trait renders it powerfully attractive to nearby electrons, engendering strong electrochemical forces that enable Methylene Blue to step forward in times of dire need. In cases of cyanide poisoning, which acts by obstructing the normal transport of oxygen into our cells, Methylene Blue acts to bypass the Electron Transport Chain mechanism blocked by the cyanide molecule and reinstate oxygen consumption to the mitochondria, restoring equilibrium. Moreover, in healthy cells, it supplements baseline oxygen consumption, thereby enhancing ATP/energy production—a vital facet of cellular vitality. Methylene Blue’s versatility extends to its ability to traverse the formidable blood-brain barrier, where it has a powerful affinity for neuronal mitochondria. Here, it reduces cellular inflammation and propels cellular oxygen uptake and respiration, vital components of neurological health. Beyond being a formidable electron acceptor, Methylene Blue is equally adept at electron donation, endowing it with potent antioxidant capabilities. In an electrochemically modified state, it transcends mitochondrial confines to fortify the capacity of blood cells to ferry increased oxygen supplies to tissues throughout the body.⁵

TOXICOLOGY

Methylene Blue boasts an admirable track record of safety, even in substantial doses, as evidenced by studies⁴. Nevertheless, caution is advised when considering its use, especially for women who are pregnant, nursing, or may become pregnant, as well as individuals seeking to harness its anti-depressive properties. Methylene Blue exerts its anti-depressive effects partly by acting as a potent MAO inhibitor, a mechanism that warrants a thorough review with a healthcare provider to avert potential complications arising from interactions with other drugs. Moreover, it is crucial to note that Methylene Blue is contraindicated for individuals with the rare G6PD deficiency.

One noteworthy characteristic of Methylene Blue is its hormetic nature, wherein its efficacy and safety are more pronounced at lower therapeutic doses. At these levels, it exhibits its antioxidant and inflammation-reducing qualities most effectively, while significantly higher dosages may paradoxically introduce oxidative and inflammation-promoting attributes⁵. Hence, it is imperative to specify the intended dosage when discussing Methylene Blue, as distinct dose ranges yield distinct outcomes.

Current clinical research aligns with these considerations, advocating for therapeutic dosages falling within the range of 0.5mg to 4mg per kilogram of body weight. This dosage range has been proven safe and efficacious in stimulating mitochondrial respiration in humans⁵, exemplifying the delicate balance required to harness Methylene Blue’s potential benefits while ensuring the utmost safety in its usage. It is also critical to illuminate the fact that Methylene Blue that is manufactured for industrial uses or for use in aquariums is not safe for use in humans because it contains impurities and toxic heavy metals that do not affect its industrial uses. Only pharmaceutical grade USP Methylene Blue should be used for topical, IV, or oral use in humans.

CONCLUSION:

In comparison to many modern pharmacological therapies with toxic, often unknown side effects, Methylene Blue, with its unassuming chemical structure, multifaceted attributes, and generally recognized history of safety and efficacy emerges as a potentially powerful pivotal player in the battle against many of the symptoms and root causes of modern diseases. Its role as an electron mediator, both accepting and donating, and its remarkable affinity for mitochondria and cellular respiration, contribute to its arsenal of therapeutic virtues. As science delves deeper into its potential, when combined with smart lifestyle, diet, and exercise choices, Methylene Blue beckons as a beacon of hope, offering innovative solutions to address the root-cause challenges posed by oxidative stress and inflammation, and for the opportunity to maximize wellness and longevity.

References

1 Anzelle Delport, B. H. (2017, Jine 15). The monoamine oxidase inhibition properties of selected structural analogues of methylene blue. Retrieved from Science Direct: www.sciencedirect.com/science/article/abs/pii/S0041008X1400?via%3Dihub
2 BASF. (2015). basf.com. Retrieved from Pioneering thinker - then and now: Methylene blue: https://www.basf.com/global/en/media/magazine/creatingchemistrystories/2015/pioneer-thinker-then-and-now-methlyene-blue.html#accordion_v2-afc91de968-item-71f8071f5c
3 Clinic, E. (2023, October 2). Extensive Health Benefits of Methylene Blue. Retrieved from Earth Clinic: earthclinic.com
4 Crossley, C. W. (2002). Methylene Blue - a theraputic dye for all seasons? Retrieved from Journal of Chemotherapy: https://www.tandfonline.com/doi/10.1179/joc.2002.14.5.431
5 F. Gonzalas-Lima, A. A. (2015). Protection against neurodegeneration with low-dose methylene blue and near-infared light. Frontiers in Cellular Neuroscience Vol 9 Article 179.
6 Filomena Puntillo, M. G. (2020, July 23). Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review. Retrieved from Advanced Theraputics: https:/doi.org/10.1007/s12325-020-01422-x
7 Gonzalez-Lima, D. F. (2022, June 16). Methylene Blue: How It May Boost Mitochondrial Function for Better Overall Health. (D. J. Mercola, Interviewer)
8 Han, S. W. (2021). Methylene Blue Application to Lessen Pain: Its Alalgesic Effect and Mechanism. Frountiers in Neuroscience, 1.
9 Harvard Health Publishing. (2020). Toxic Beauty - Are your personal care products putting you at risk? Harvard Medical School.
10 Heeney, R. (2022, March 4). What is Methylene Blue?
11 Huijing Zue, A. T. (2021, December 1). The potentials of Methylene Blue as an Anti-Aging Drug. Retrieved from Cells: https://doi.org/10.3390/cells10123379
12 Landes, D. S. (1969). The Unbound Prometheus. Press Syndicate of the University of Cambridge. Press Syndicate of the University of Cambridge.
13 Luodan Yang, H. Y. (2020, September 19). Mitochondria as a target for neuroprotection: role ofmethylene blue and photobiomodulation. Retrieved from Translational Neurodegeneration: www.biomedcentral.com
14 Omar ME Abdel-Salam, E. R. (2021, December). Methylene Blue Protects Against Acute Ethanol-Induced Oxidative Stress and Organ Damage. Retrieved from International Journal of Halal Research.
15 Zheng-Mei Xiong, X. M. (2021, April 19). Ultraviolet radiation protection potentials of Methylene Blue for huiman skin and coral reef health. Retrieved from Nature.com: www.nature.com/scientificreports

ABOUT THE AUTHORS

Matthew Frederick
Instagram: @matthew_frederick_official
X: @matthew_frederick_official
LinkedIn: https://www.linkedin.com/in/matthew-frederick-nobiesse/

Matthew Frederick is President and CEO of Nobiesse Laboratories. His work is focused on exploring the boundaries of wellness, health and longevity and to developing high-quality, personalized products and services that can help people to live longer, happier, more fulfilled lives. He created Nobiesse to address a fundamental lack of quality Do-No-Harm products in the consumer market and to lead a charge to transform broken consumer care, medical and financial models around the world. Frederick holds an BS from Northeastern University and has completed the Executive Development Program at The Wharton School at the University of Pennsylvania. He is based in Parsippany, New Jersey.

Instagram: @NobiesseLabs
X: Follow @NobiesseLabs

About Nobiesse Insights

Nobiesse Insights publishes original articles, research summaries and opinion papers that provide insights for consumers. Our goal is to draw upon published clinical research and experience from throughout our professional services organizations, and that of clinical researchers and practitioners in academia and business, to advance the conversation through critical exploration of clinical research and thought leadership on a broad spectrum of topics of interest to people seeking to improve their nutritional, health, financial and longevity awareness. Nobiesse Insights is an imprint of Nobiesse Laboratories, LLC.

About this publication

This publication contains general information only, and none of Nobiesse Laboratories, LLC, its member firms, or its and their affiliates or their respective employees or associates are, by means of this publication, rendering nutritional, medical, accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services, nor should it be used as a basis for any decision or action that may affect your health, finances or your business. Before making any decision or taking any action that may affect your health, finances or your business, you should consult a qualified professional adviser or medical professional.

None of Nobiesse Laboratories, LLC, its member firms, employees, or its and their respective affiliates shall be responsible for any loss or injury whatsoever sustained by any person who relies on this publication.

About Nobiesse

Nobiesse refers to one or more of Nobiesse Laboratories, LLC, its network of member firms, and their related entities. Nobiesse and each of its related entities are legally separate and independent entities. Nobiesse Laboratories, LLC (also referred to as “Nobiesse”) does not provide services to clients. In the United States, Nobiesse refers to one or more of the US member firms of Nobiesse Laboratories, LLC, their related entities that operate using the “Nobiesse” name in the United States and their respective affiliates. Certain services may not be available to customers and clients in all areas. Please see www.nobiesse.com to learn more about our global network of related entities.

Disclaimer: The information provided in this white paper is intended for informational and educational purposes only and is not intended to constitute nutritional, medical, or financial advice. This information has not been evaluated by the Food and Drug Administration (FDA), and the content presented here is not intended to diagnose, treat, cure, or prevent any medical condition or disease. Readers are encouraged to seek advice from a qualified physician or healthcare provider for medical concerns or conditions. The authors and publishers of this white paper do not endorse or recommend specific nutritional, medical, or treatments, therapies, or interventions, or specific financial investment options, products or programs. Any decisions regarding medical treatment should be made in consultation with a licensed healthcare professional. Any decisions regarding financial investments, financial planning, or tax-related questions should be made in consultation with a licensed finance professional. This information is not a substitute for professional medical advice, diagnosis, or treatment, and the FDA has not reviewed or approved any claims made in this white paper.

Copyright Nobiesse Laboratories, LLC 2023. All Rights Reserved. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons License, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless otherwise indicated in a credit line to the material. If material is not included in the article’s Creative Commons license, and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.